vs
Side-by-side financial comparison of Northfield Bancorp, Inc. (NFBK) and SBC Medical Group Holdings Inc (SBC). Click either name above to swap in a different company.
Northfield Bancorp, Inc. is the larger business by last-quarter revenue ($41.3M vs $39.6M, roughly 1.0× SBC Medical Group Holdings Inc). SBC Medical Group Holdings Inc runs the higher net margin — 35.9% vs -1545.5%, a 1581.4% gap on every dollar of revenue. On growth, Northfield Bancorp, Inc. posted the faster year-over-year revenue change (12.7% vs -10.9%). Northfield Bancorp, Inc. produced more free cash flow last quarter ($52.5M vs $51.2M). Over the past eight quarters, Northfield Bancorp, Inc.'s revenue compounded faster (15.0% CAGR vs -15.0%).
Northfield Bancorp, Inc. is a regional bank holding company based in the United States, operating primarily across the U.S. Northeast region. It provides a full range of personal and commercial banking services including deposit accounts, mortgage loans, commercial lending, and wealth management solutions for retail consumers, small to medium-sized businesses and local community clients.
SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.
NFBK vs SBC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $41.3M | $39.6M |
| Net Profit | $-27.4M | $14.2M |
| Gross Margin | — | 73.1% |
| Operating Margin | -1263.3% | 32.5% |
| Net Margin | -1545.5% | 35.9% |
| Revenue YoY | 12.7% | -10.9% |
| Net Profit YoY | -343.6% | 117.2% |
| EPS (diluted) | $-0.68 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $41.3M | $39.6M | ||
| Q3 25 | $39.2M | $43.4M | ||
| Q2 25 | $38.9M | $43.4M | ||
| Q1 25 | $34.8M | $47.3M | ||
| Q4 24 | $36.7M | $44.4M | ||
| Q3 24 | $31.8M | $53.1M | ||
| Q2 24 | $31.5M | $53.1M | ||
| Q1 24 | $31.3M | $54.8M |
| Q4 25 | $-27.4M | $14.2M | ||
| Q3 25 | $10.8M | $12.8M | ||
| Q2 25 | $9.6M | $2.5M | ||
| Q1 25 | $7.9M | $21.5M | ||
| Q4 24 | $11.3M | $6.5M | ||
| Q3 24 | $6.5M | $2.8M | ||
| Q2 24 | $6.0M | $18.5M | ||
| Q1 24 | $6.2M | $18.8M |
| Q4 25 | — | 73.1% | ||
| Q3 25 | — | 70.6% | ||
| Q2 25 | — | 69.2% | ||
| Q1 25 | — | 79.7% | ||
| Q4 24 | — | 76.3% | ||
| Q3 24 | — | 81.5% | ||
| Q2 24 | — | 74.2% | ||
| Q1 24 | — | 72.1% |
| Q4 25 | -1263.3% | 32.5% | ||
| Q3 25 | 37.7% | 36.6% | ||
| Q2 25 | 35.6% | 33.6% | ||
| Q1 25 | 31.0% | 51.1% | ||
| Q4 24 | 38.0% | 10.6% | ||
| Q3 24 | 27.9% | 26.1% | ||
| Q2 24 | 29.1% | 51.4% | ||
| Q1 24 | 27.2% | 44.6% |
| Q4 25 | -1545.5% | 35.9% | ||
| Q3 25 | 27.4% | 29.6% | ||
| Q2 25 | 24.6% | 5.7% | ||
| Q1 25 | 22.6% | 45.4% | ||
| Q4 24 | 30.7% | 14.7% | ||
| Q3 24 | 20.5% | 5.3% | ||
| Q2 24 | 18.9% | 34.8% | ||
| Q1 24 | 19.9% | 34.2% |
| Q4 25 | $-0.68 | $0.15 | ||
| Q3 25 | $0.27 | $0.12 | ||
| Q2 25 | $0.24 | $0.02 | ||
| Q1 25 | $0.19 | $0.21 | ||
| Q4 24 | $0.27 | $0.05 | ||
| Q3 24 | $0.16 | $0.03 | ||
| Q2 24 | $0.14 | $0.20 | ||
| Q1 24 | $0.15 | $0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $164.0M | $164.1M |
| Total DebtLower is stronger | — | $42.8M |
| Stockholders' EquityBook value | $690.1M | $248.3M |
| Total Assets | $5.8B | $380.4M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $164.0M | $164.1M | ||
| Q3 25 | $131.7M | $127.4M | ||
| Q2 25 | $97.6M | $152.7M | ||
| Q1 25 | $101.7M | $132.1M | ||
| Q4 24 | $167.7M | $125.0M | ||
| Q3 24 | $232.9M | $137.4M | ||
| Q2 24 | $153.5M | — | ||
| Q1 24 | $238.8M | — |
| Q4 25 | — | $42.8M | ||
| Q3 25 | — | $21.1M | ||
| Q2 25 | — | $7.1M | ||
| Q1 25 | — | $6.9M | ||
| Q4 24 | $666.4M | $6.6M | ||
| Q3 24 | — | $823.2K | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $690.1M | $248.3M | ||
| Q3 25 | $719.6M | $248.0M | ||
| Q2 25 | $710.3M | $244.6M | ||
| Q1 25 | $711.1M | $226.4M | ||
| Q4 24 | $704.7M | $195.1M | ||
| Q3 24 | $699.6M | $205.0M | ||
| Q2 24 | $693.0M | $8.8M | ||
| Q1 24 | $698.4M | $9.0M |
| Q4 25 | $5.8B | $380.4M | ||
| Q3 25 | $5.7B | $321.4M | ||
| Q2 25 | $5.7B | $315.3M | ||
| Q1 25 | $5.7B | $284.6M | ||
| Q4 24 | $5.7B | $266.1M | ||
| Q3 24 | $5.7B | $296.5M | ||
| Q2 24 | $5.7B | $19.5M | ||
| Q1 24 | $5.9B | $19.8M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.09× | ||
| Q2 25 | — | 0.03× | ||
| Q1 25 | — | 0.03× | ||
| Q4 24 | 0.95× | 0.03× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $53.7M | $52.0M |
| Free Cash FlowOCF − Capex | $52.5M | $51.2M |
| FCF MarginFCF / Revenue | 127.1% | 129.3% |
| Capex IntensityCapex / Revenue | 2.8% | 2.0% |
| Cash ConversionOCF / Net Profit | — | 3.66× |
| TTM Free Cash FlowTrailing 4 quarters | $89.2M | $23.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $53.7M | $52.0M | ||
| Q3 25 | $13.9M | $-20.9M | ||
| Q2 25 | $14.1M | $-8.3M | ||
| Q1 25 | $9.4M | $1.9M | ||
| Q4 24 | $31.1M | $-7.3M | ||
| Q3 24 | $14.0M | $5.0M | ||
| Q2 24 | $6.9M | $19.2M | ||
| Q1 24 | $4.2M | $3.7M |
| Q4 25 | $52.5M | $51.2M | ||
| Q3 25 | $13.6M | $-20.9M | ||
| Q2 25 | $13.9M | $-8.6M | ||
| Q1 25 | $9.2M | $1.7M | ||
| Q4 24 | $30.0M | $-7.9M | ||
| Q3 24 | $13.7M | $4.6M | ||
| Q2 24 | $6.7M | $18.3M | ||
| Q1 24 | $3.8M | $3.0M |
| Q4 25 | 127.1% | 129.3% | ||
| Q3 25 | 34.6% | -48.3% | ||
| Q2 25 | 35.7% | -19.9% | ||
| Q1 25 | 26.3% | 3.5% | ||
| Q4 24 | 81.6% | -17.8% | ||
| Q3 24 | 43.2% | 8.7% | ||
| Q2 24 | 21.1% | 34.5% | ||
| Q1 24 | 12.1% | 5.4% |
| Q4 25 | 2.8% | 2.0% | ||
| Q3 25 | 0.8% | 0.1% | ||
| Q2 25 | 0.6% | 0.7% | ||
| Q1 25 | 0.7% | 0.5% | ||
| Q4 24 | 3.1% | 1.3% | ||
| Q3 24 | 0.7% | 0.8% | ||
| Q2 24 | 0.8% | 1.6% | ||
| Q1 24 | 1.4% | 1.3% |
| Q4 25 | — | 3.66× | ||
| Q3 25 | 1.29× | -1.63× | ||
| Q2 25 | 1.48× | -3.39× | ||
| Q1 25 | 1.20× | 0.09× | ||
| Q4 24 | 2.76× | -1.12× | ||
| Q3 24 | 2.14× | 1.77× | ||
| Q2 24 | 1.16× | 1.04× | ||
| Q1 24 | 0.68× | 0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NFBK
Segment breakdown not available.
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
